We provide you with 20 years of free, institutional-grade data for ORGO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ORGO. Explore the full financial landscape of ORGO stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| ERANI ALBERT | Sale | -431,786 | $4.37 | $1,884,875 | 2024-01-11 |
| ERANI ALBERT | Sale | -50,000 | $2.07 | $103,545 | 2023-04-14 |
| Grow Brian | Sale | -2,408 | $2.13 | $5,129 | 2023-04-04 |
| Montecalvo Antonio S. | Sale | -2,097 | $2.13 | $4,467 | 2023-04-04 |
| Gillheeney Gary S. | Sale | -6,470 | $2.13 | $13,781 | 2023-04-04 |
| Freedman Lori | Sale | -2,339 | $2.13 | $4,982 | 2023-04-04 |
| Bilbo Patrick | Sale | -2,678 | $2.13 | $5,704 | 2023-04-04 |
| Gillheeney Gary S. | Grant, award...etc | 896,414 | 2023-02-24 | ||
| Driscoll Michael Joseph | Grant, award...etc | 65,737 | 2023-02-24 | ||
| Duraibabu Prathyusha | Grant, award...etc | 65,737 | 2023-02-24 | ||
| Quintero Gilberto | Grant, award...etc | 65,737 | 2023-02-24 | ||
| Korfin Michele Ilene | Grant, award...etc | 65,737 | 2023-02-24 | ||
| Giacomin Jon L | Grant, award...etc | 65,737 | 2023-02-24 | ||
| Leibowitz Arthur S | Grant, award...etc | 65,737 | 2023-02-24 | ||
| Freedman Lori | Grant, award...etc | 278,884 | 2023-02-24 | ||
| Bilbo Patrick | Grant, award...etc | 327,386 | 2023-02-24 | ||
| Grow Brian | Grant, award...etc | 291,009 | 2023-02-24 | ||
| Francisco David | Grant, award...etc | 242,508 | 2023-02-24 | ||
| Montecalvo Antonio S. | Grant, award...etc | 99,428 | 2023-02-24 | ||
| Montecalvo Antonio S. | Sale | -1,966 | $2.92 | $5,741 | 2023-02-17 |
| Freedman Lori | Sale | -4,400 | $2.92 | $12,848 | 2023-02-17 |
| Grow Brian | Sale | -4,145 | $2.92 | $12,103 | 2023-02-17 |
| Francisco David | Sale | -4,459 | $2.92 | $13,020 | 2023-02-17 |
| Bilbo Patrick | Sale | -5,535 | $2.92 | $16,162 | 2023-02-17 |
| Gillheeney Gary S. | Sale | -25,304 | $2.92 | $73,888 | 2023-02-17 |
| KATZ MICHAEL W | Open Market Purchase | 6,000 | $2.57 | 2022-11-22 | |
| Grow Brian | Derivatives Exercise | 805 | 2022-08-24 | ||
| Leibowitz Arthur S | Open Market Purchase | 3,000 | $4.75 | 2022-08-15 | |
| Driscoll Michael Joseph | Open Market Purchase | 5,000 | $4.8 | 2022-08-15 | |
| Gillheeney Gary S. | Derivatives Exercise | 505,050 | 2022-07-01 | ||
| ERANI ALBERT | Sale | -60,000 | $5.3 | $318,000 | 2022-06-13 |
| ERANI ALBERT | Sale | -340,000 | $5.41 | $1,839,400 | 2022-06-08 |
| Gillheeney Gary S. | Sale | -247,334 | $5.52 | $1,365,284 | 2022-06-03 |
| Gillheeney Gary S. | Derivatives Exercise | 247,334 | 2022-06-03 | ||
| Gillheeney Gary S. | Sale | -226,804 | $5.71 | $1,295,051 | 2022-05-31 |
| Gillheeney Gary S. | Derivatives Exercise | 226,804 | 2022-05-31 | ||
| Gillheeney Gary S. | Sale | -197,336 | $5.84 | $1,152,442 | 2022-05-25 |
| Gillheeney Gary S. | Derivatives Exercise | 197,336 | 2022-05-25 | ||
| Gillheeney Gary S. | Sale | -263,689 | $5.46 | $1,439,742 | 2022-05-20 |
| Gillheeney Gary S. | Derivatives Exercise | 263,689 | 2022-05-20 | ||
| KATZ MICHAEL W | Open Market Purchase | 10,000 | $5.99 | 2022-05-18 | |
| Gillheeney Gary S. | Sale | -314,837 | $6.06 | $1,907,912 | 2022-05-17 |
| Gillheeney Gary S. | Derivatives Exercise | 314,837 | 2022-05-17 | ||
| Quintero Gilberto | Grant, award...etc | 23,913 | 2022-05-05 | ||
| Korfin Michele Ilene | Grant, award...etc | 23,913 | 2022-05-05 | ||
| Gillheeney Gary S. | Sale | -9,789 | $7.89 | $77,235 | 2022-04-05 |
| Grow Brian | Sale | -1,977 | $7.89 | $15,599 | 2022-04-05 |
| Montecalvo Antonio S. | Sale | -2,738 | $7.89 | $21,603 | 2022-04-05 |
| Bilbo Patrick | Sale | -2,497 | $7.89 | $19,701 | 2022-04-05 |
| Freedman Lori | Sale | -2,984 | $7.89 | $23,544 | 2022-04-05 |
| Montecalvo Antonio S. | Derivatives Exercise | 68,504 | 2022-03-11 | ||
| Montecalvo Antonio S. | Sale | -107,436 | $8.52 | $915,355 | 2022-03-11 |
| Giacomin Jon L | Grant, award...etc | 20,547 | 2022-02-17 | ||
| Duraibabu Prathyusha | Grant, award...etc | 20,547 | 2022-02-17 | ||
| Leibowitz Arthur S | Grant, award...etc | 20,547 | 2022-02-17 | ||
| Montecalvo Antonio S. | Sale | -718 | $7.78 | $5,586 | 2022-02-17 |
| Montecalvo Antonio S. | Grant, award...etc | 14,383 | 2022-02-17 | ||
| Bilbo Patrick | Sale | -937 | $7.78 | $7,290 | 2022-02-17 |
| Bilbo Patrick | Grant, award...etc | 52,926 | 2022-02-17 | ||
| Grow Brian | Sale | -799 | $7.78 | $6,216 | 2022-02-17 |
| Grow Brian | Grant, award...etc | 45,143 | 2022-02-17 | ||
| Freedman Lori | Sale | -765 | $7.78 | $5,952 | 2022-02-17 |
| Freedman Lori | Grant, award...etc | 41,843 | 2022-02-17 | ||
| Francisco David | Sale | -2,829 | $8.03 | $22,717 | 2022-02-17 |
| Francisco David | Grant, award...etc | 40,348 | 2022-02-17 | ||
| Gillheeney Gary S. | Sale | -4,085 | $7.78 | $31,781 | 2022-02-17 |
| Gillheeney Gary S. | Grant, award...etc | 280,199 | 2022-02-17 | ||
| Driscoll Michael Joseph | Grant, award...etc | 20,547 | 2022-02-17 | ||
| KATZ MICHAEL W | Open Market Purchase | 500 | $9.65 | 2021-12-14 | |
| KATZ MICHAEL W | Open Market Purchase | 2,600 | $9.75 | 2021-12-06 | |
| KATZ MICHAEL W | Open Market Purchase | 1,000 | $9.75 | 2021-12-01 | |
| KATZ MICHAEL W | Open Market Purchase | 2,000 | $9.82 | 2021-11-30 | |
| Duraibabu Prathyusha | Grant, award...etc | 11,340 | 2021-11-23 | ||
| GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 | Open Market Purchase | 25,000 | $9.93 | 2021-11-22 | |
| NUSSDORF GLENN H | Open Market Purchase | 25,000 | $9.93 | 2021-11-22 | |
| KATZ MICHAEL W | Open Market Purchase | 5,000 | $11.3 | 2021-11-19 | |
| Bilbo Patrick | Derivatives Exercise | 30,450 | 2021-11-12 | ||
| KATZ MICHAEL W | Open Market Purchase | 12,000 | $13.55 | 2021-08-19 | |
| Leibowitz Arthur S | Grant, award...etc | 5,000 | 2021-08-05 | ||
| Gillheeney Gary S. | Sale | -300,000 | $14.58 | $4,374,000 | 2021-07-20 |
| Gillheeney Gary S. | Derivatives Exercise | 300,000 | 2021-07-20 | ||
| Erani Dennis | Sale | -9,106 | $18.97 | $172,741 | 2021-06-28 |
| ERANI ALBERT | Sale | -150,000 | $15.31 | $2,296,500 | 2021-06-10 |
| Albert Erani Family Trust dated 12/29/2012 | Sale | -150,000 | $15.31 | $2,296,500 | 2021-06-10 |
| ERANI ALBERT | Sale | -254,612 | $16.22 | $4,129,807 | 2021-06-08 |
| Albert Erani Family Trust dated 12/29/2012 | Sale | -254,612 | $16.22 | $4,129,807 | 2021-06-08 |
| NUSSDORF GLENN H | Sale | -3,887,500 | $16.4 | $63,755,000 | 2021-05-28 |
| Ades Alan A. | Sale | -3,887,500 | $16.4 | $63,755,000 | 2021-05-28 |
| Wisdom Starr | Sale | -566,297 | $4.5 | $2,548,337 | 2021-05-18 |
| Giacomin Jon L | Grant, award...etc | 5,319 | 2021-05-11 | ||
| Gillheeney Gary S. | Sale | -7,890 | $19.83 | $156,459 | 2021-04-08 |
| Bilbo Patrick | Sale | -2,497 | $19.83 | $49,516 | 2021-04-05 |
| Grow Brian | Sale | -1,977 | $19.83 | $39,204 | 2021-04-05 |
| Freedman Lori | Sale | -1,975 | $19.83 | $39,164 | 2021-04-05 |
| Gillheeney Gary S. | Sale | -6,265 | $19.83 | $124,235 | 2021-04-05 |
| Montecalvo Antonio S. | Sale | -1,770 | $19.83 | $35,099 | 2021-04-05 |
| Francisco David | Grant, award...etc | 10,965 | 2021-02-18 | ||
| Montecalvo Antonio S. | Grant, award...etc | 8,260 | 2021-02-18 | ||
| Freedman Lori | Grant, award...etc | 8,808 | 2021-02-18 | ||
| Grow Brian | Grant, award...etc | 10,782 | 2021-02-18 | ||
| Bilbo Patrick | Grant, award...etc | 10,782 | 2021-02-18 |
The information provided in this report about ORGO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Organogenesis Holdings Inc(NASDAQ:ORGO) 
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic allograft wound cove...
Website: http://organogenesis.com
Founded: 1985
Full Time Employees: 835
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic